Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Fast & Convenient Real Time PCR Setup
Friday, December 13, 2013
INTEGRA demonstrates the use of VIAFLO VOYAGER in new customer testimonial video.

Bio-Rad Launches PrimePCR™ Assays for Droplet Digital™ PCR
Thursday, December 12, 2013
Bio-Rad Laboratories announces the release of its PrimePCR assays for Droplet Digital PCR systems, expanding their current offering by an additional 46 mutation detection assays and 323 copy number assays.

Modifying the Oligo Backbone - Advice for PNA and UNA Chemistry
Tuesday, December 10, 2013
Link Technologies provides key protocols for oligonucleotide synthesis and modification.

Bio-Rad Launches CFX Manager™ Software for Real-Time PCR
Wednesday, November 27, 2013
The software allows users to quickly and easily set up a real-time PCR experiment, assess data quality, and interpret results.

Get Prime Thermal Cyclers at a Low Price with Latest Offer from Techne!
Tuesday, November 26, 2013
Techne’s Prime Thermal Cyclers delivers rapid, effective PCR solutions.

New Microtube Shaking Incubator
Tuesday, November 19, 2013
New addition to Labnet’s popular constant temperature equipment line.

Compact All-in-One Multiple Format Mixer
Tuesday, November 12, 2013
An accurate, reliable, compact and simple-to-use multi-format mixer.

Accel-NGS™ PCR-free DNA Library Kit Launched for NGS Systems
Tuesday, November 12, 2013
Swift Biosciences, Inc. announced the launch of the Accel-NGS™ PCR-free DNA Library Kit for Illumina Next Generation Sequencing (NGS) systems.

Safe, Accurate, Easy Repeat Dispensing
Wednesday, October 30, 2013
Even for difficult to handle samples.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 581
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv